Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-04 Beta-adrenoceptor blocking drugs
| Labetalol |
|
Formulary
|
Tablets 100mg, 200mg |
 NICE: Hypertension in pregnancy: diagnosis and management |
|
| Metoprolol |
|
Formulary
|
Tablets 50mg Not first line. Use when beta blocker with a short half life is required. |
|
| Propranolol |
|
Formulary
|
Tablets 10mg, 40mg, 80mg Not recommended for cardiac indications |
|
|
| Nebivolol |
|
Formulary
|
Tablets 5mg Not first line. |
|
|
| Nadolol |
|
Formulary
|
Tablets 80mg
Long QT syndrome.
On advice of cardiology only. All dose titrations must be carried out by the initiating cardiologist. |
 LSCMMG: Nadolol NMR |
|
Links
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**- Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
- LSC Statin Intolerance Pathway
- LSCMMG: Atrial Fibrillation Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease
- LSCMMG: Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- LSCMMG: Nadolol NMR
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE: Hypertension in pregnancy: diagnosis and management
- Renal: Enhanced Supportive Kidney Care Guideline